BofA downgraded IGM Biosciences (IGMS) to Underperform from Neutral with a price target of 75c, down from $2, after the company released ...

The appointment of Dr. Banerjee culminates Artiva’s efforts to build a seasoned development team with strong expertise in autoimmunity and cell therapy that includes the following recent additions: ...